Cambridge Commodities expands ingredient and finished product range with sustainable softgels

Global ingredient supplier Cambridge Commodities is expanding its offering to include premium softgel formulations that cater for a wide range of consumer need states

picture of

Breaking News

CureVac and Rentschler Biopharma ramp up vaccine manufacture

The companies aim to produce more than 100 million doses of the CureVac vaccine per year in Laupheim

Eleva secures up to $74m to advance drug candidate

The company also announced the addition of Dr Ralf Smit to its executive board

Vectura earns $11m milestone with Hikma generic launch

The launch of the product follows approval by the US FDA

The business and patient case for drug delivery device innovation in biosimilar products

Biosimilar development in the United States is at an important juncture, reports Darren Mansell, Regulatory Affairs ...

Orgenesis signs joint venture with Cure Therapeutics

The agreement aims to to advance point-of-care development and commercialisation of cell and gene therapies

Merck and Artios Pharma announce oncology collaboration

The agreement does not include Artios’s lead programmes, Polθ and ATR inhibitors, for which it will retain all rights

Derisking topical formulation development with multifactorial disease models

Today’s market for topical pharmaceuticals is valued at around $95 billion, with development efforts focused on small ...

UK government secures an additional 2m Moderna vaccine doses

On October 27, the Medicines and Healthcare products Regulatory Agency started the rolling review process of mRNA-1273 ...

European Commission purchases 80m vaccine doses from Moderna

The agreement gives the commission the option to purchase an additional 80 million doses up to a total of 160 million

Packaging prefilled syringes: solving the sterility conundrum

What’s the key to ensuring sterility when packaging prefilled syringes?

Drug dose delivery development, manufacturing and commercialisation trends: part II

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central ...

Drug dose delivery development, manufacturing and commercialisation trends: part I

In the wake of patient-centricity in the pharmaceutical industry, drug delivery technologies have emerged as a central ...

Osivax wins Hello Tomorrow global challenge drug discovery category

The company says its platform could also provide a universal coronavirus vaccine, complementing vaccines currently in ...

Telstar increases freezer production for vaccine storage demand

The line was developed using the company’s in-house cold storage technology